Page last updated: 2024-08-21

cyclopentane and Adrenal Cortex Cancer

cyclopentane has been researched along with Adrenal Cortex Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amendola, D; Avena, P; Campana, C; Carpinelli, G; Casaburi, I; Cerquetti, L; Chimento, A; De Luca, A; Domanico, F; Fallo, F; Malivindi, R; Martire, E; Pezzi, V; Rizza, P; Sirianni, R; Stigliano, A; Zolea, F1

Other Studies

1 other study(ies) available for cyclopentane and Adrenal Cortex Cancer

ArticleYear
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo.
    Oncotarget, 2015, Aug-07, Volume: 6, Issue:22

    Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Animals; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Cyclopentanes; DNA Damage; Female; Humans; Male; Mice; Mice, Nude; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction

2015